Skip to main content
< All Topics
You are here:
Print

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

Table of Contents